GP Vivas · dermatological-presentations
Psoriasis — structured viva
Structured oral on psoriasis: defending the multisystem framing with comorbidity screening, arguing topical potency choices, walking the systemic ladder with monitoring schedules, ranking biologics from Cochrane network meta-analysis evidence, and closing on lifestyle co-prescription and emergency variants.
On this page
Study tools
Target exams
RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'A colleague calls psoriasis a skin disease managed with moisturiser. Dismantle that in two minutes.' The viva branches through diagnosis and variants, the comorbidity mandate, topical ladder cautions, phototherapy and systemics, biologic hierarchy, and lifestyle links.
Stem
You are the GP. The registrar says psoriasis is 'moisturiser and hope'. Correct them. [2]
References6ShowHide
- [1]Elmets CA, Korman NJ, Prater EF et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Journal of the American Academy of Dermatology, 2021.PMID 32738429
- [2]Elmets CA, Leonardi CL, Davis DMR et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. Journal of the American Academy of Dermatology, 2019.PMID 30772097
- [3]Menter A, Strober BE, Kaplan DH et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Journal of the American Academy of Dermatology, 2019.PMID 30772098
- [4]Mastorino L, Leo F, Frigatti G et al. Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review. American journal of clinical dermatology, 2025.PMID 40856907
- [5]Lebwohl MG, Merola JF, Rowland K et al. Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis. British Journal of Dermatology, 2023.PMID 37022762
- [6]Sbidian E, Chaimani A, Guelimi R et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. The Cochrane database of systematic reviews, 2023.PMID 37436070